WASHINGTON, Sept. 28 (TNSLrpt) -- The Health and Human Services Inspector General issued the following report (No. OEI-03-26-00080) entitled "Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2024 Average Sales Prices" filed under the Centers for Medicare and Medicaid Services:

Here are excerpts:

* * *

Why OIG Did This Review

* Medicare Part B annually spends billions of dollars to cover a limited number of outpati . . .

Click here for more information about our products